Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$8,995,523
8 notices · 318,684 sh
Oct 2025 to Oct 2026
Reported ·
$2,280,029
45 sales · 35 buys · $1,803,069 bought
Oct 2025 to Jun 2026
The two figures cover different periods.
None of the 45 reported sales carry the 10b5-1 box. Together they are 0.50% of the shares on issue.
under a no plan named▼ sale▲ buysize is dollars
Form 144 notices, newest first
2026-07-22Cambrian BioPharma Inc, 10% Stockholder$3,642,675
130,142 shno plan dateForm 4s on file end Jun 23144 ↗ 2026-04-29Cambrian BioPharma Inc, 10% Stockholder$4,956,786
155,142 shno plan date144 ↗ Form 4, 2026-06-01: sold 25,000 at $20.02
Form 4 ↗2026-02-24Celebi John, PRESIDENT AND CEO$116,356
3,374 shno plan dateno Form 4 on file144 ↗ 2026-02-18Peyer James, Fomer Director$25,769
950 shno plan dateno Form 4 on file144 ↗ 2026-01-27RINGO WILLIAM R, Former Director$11,486
1,169 shno plan dateno Form 4 on file144 ↗ 2025-12-09Peyer James, Former Director$6,707
Form 4, 2025-12-10: sold 6,612 at $8.25
Form 4 ↗2025-12-04Cambrian BioPharma Inc, 10% Stockholder$50,901
5,844 shno plan date144 ↗ Form 4, 2025-12-08: sold 21,295 at $10.93
Form 4 ↗2025-12-04Cambrian BioPharma Inc, 10% Stockholder$184,843
21,222 shno plan dateno Form 4 on file144 ↗